Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
biopharma-reporter
6h
Roche acquires CAR-T developer Poseida Therapeutics for $1.5 billion
The acquisition will grant Roche full ownership over a pipeline of allogeneic CAR-T therapy candidates, including two ...
biopharma-reporter
7h
Amgen announces positive Phase 2 results for its GLP-1-GIP weight loss drug
MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Concedes in CA House race
Mass arrests at parade
Wins reelection after recount
MD prison inmate killed
Boise State withdraws
Meets Trump at Mar-a-Lago
Habitat protections plan
Cybertruck crash kills 3
One-month doping ban
'City under the ice'
UKR energy sector attacked
Costco recalls eggs
Court upholds TX razor wire
Settles harassment lawsuit
Asthma attack treatment
Abortions fell 2% in 2022
Travel advisory downgraded
Menendez seeks new trial
Bail denied by third judge
Capitol Hill visit on Dec 5
Thanksgiving in space
Uber faces FTC probe
AU passes social media ban
Ohtani seeks baseball cards
Retires after 14 seasons
Stowaway found on flight
NM man awarded $412M+
Residents sue Givaudan
Jan. 6 coverage suit tossed
China probes top official
Feedback